Meliha Esra Bilici

Dr. Meliha Esra Bilici

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2025 in Therapeutic Advances in Endocrinology and Metabolism
Verified
Journal Article
Open access
MBMeliha Esra Bilici
Meliha Esra Bilici
ZŞZeynep Şıklar
Zeynep Şıklar
EÖElif Özsu
Elif Özsu
ZAZehra Aycan
Zehra Aycan
RURukiye Uyanık
Rukiye Uyanık
MBMerih Berberoğlu
Merih Berberoğlu
Objective: Recent guidelines about Non-classical Congenital Adrenal Hyperplasia (NCCAH) indicate that if the peak cortisol response to the adrenocorticotropic hormone (ACTH) stimulation test is 10 ng/dL and had been investigated for 11 common CYP21A2 mutations. A peak cortisol response below 18 µg/dL was insufficient for our polyclonal assay. The cases were divided into two groups: Inadequate/low cortisol response group (LCR; n : 11) and adequate/normal response group ( n : 25). We correlated biallelic genotype and cortisol response. Genotypes were classified as mild/mild (M/M), mild/severe (M/S), and heterozygous on a single allele based on the genotype’s effect on enzyme activity. P30L, V281L, P453S, and R339H are mild NCCAH mutations, whereas Q318X, R356W, exon 6 cluster mutations, Intron2A, and 8 bp deletions were severe. All cohorts with the V281L variant were separated into three groups (M/M, M/S, mild/undefined) and evaluated separately. Results: Almost one-third of patients had inadequate cortisol reserve. In the LCR group, 17-OHP 0’ levels were greater, but cortisol 0’ levels were lower, with no difference in stimulated responses (15.4 ± 10.5 vs 7.8 ± 6.2, p : 0.016 for basal 17-OHP; 40.7 ± 48.6 vs 32.3 ± 26.4, p : 0.63 for stimulated 17-OHP). The 17-OHP cutoff values were found to be 4.2 and 30.4 ng/dL, with 100% specificity for both groups. In 36% of the LCR group, mild–mild mutations were found. ACTH, cortisol (0’ and peak), and 17-OHP (0’ and peak) levels were similar in mild/mild and mild/severe groups. The V281L mutation was present in 86.1% of our cohort, with inadequate cortisol response in 29% of cases with V281L mutation. Differences were observed between the 0’ and peak cortisol levels in the V281L groups, with post hoc analysis indicating a difference between one allele heterozygous (mild/undefined) and mild/severe group. Conclusion: Our findings emphasize that a significant portion of patients with the mild/mild V281 mutation exhibit inadequate cortisol responses, highlighting the importance of the ACTH stimulation test in diagnosis and the need for careful monitoring in clinical treatment, as well as consideration of genotype variations.

1 September 2020 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
EÖElif Özsu
Elif Özsu
ZSZeynep Siklar
Zeynep Siklar
MBMeliha Esra Bilici
Meliha Esra Bilici
ACAyşegül Ceran
Ayşegül Ceran
RURukiye Uyanık
Rukiye Uyanık
MBMerih Berberoğlu
Merih Berberoğlu
Objective: Standard short adrenocorticotropic hormone (ACTH) stimulation test (SST) has traditionally been used for assessing adrenal gland fuction by intravenous (iv) application. However the iv form is not readily available in all countries, including Turkey. The aim of this study was to evaluate the effectiveness of the intramuscular (im) SST. Methods: Patients underwent im SST with suspected adrenal insufficiency (Al) and hyperandrogenism. The SSTs were done with 250 mcg ACTH (Synacthen Depot ampul, concentration 1 mg/mL). The cases were divided into two groups: suspected Al (group 1 n = 87): and hyperandrogenism group (group 2 n = 124). Definite Al was defined as peak cortisol < 18 mu g/dL, suspected Al as a peak cortisol of 18-21 mu g/dL and normal result was defined as a peak cortisol >= 22 mu g/dL. Results: The mean age of the patients was 11.7 +/- 5.2 years. In 164 patients (78%) all of the peak cortisol tests were normal (>= 22 mcg/dL). The rates were 64% and 88% in group I and 2, respectively. Only 8.5% (n = 18) of all cases had an inadequate peak cortisol response of <18 mcg/dL. On follow up, 15 patients whose peak cortisol was = 10 ng/dL. Clinical findings suggestive of non-classical congenital adrenal hyperplasia and/or mutation were found in six of these cases (75%). No local and systemic side effects or allergic reactions were observed in any patient. Conclusion: IM ACTH SST is a safe, effective and reliable test in children with suspected Al. There were no local or systemic side effects, supporting the reliability of the im ACTH test.

20 November 2025 in Scientific Reports
Verified
Journal Article
Open access
MBMeliha Esra Bilici
Meliha Esra Bilici
ZÖZühal Örnek
Zühal Örnek
This study aimed to evaluate whether being metabolically healthy (MHO) provides protection against micronutrient deficiencies, particularly vitamin B12 deficiency, in obese children and to investigate the relationship between vitamin B12 levels and metabolic health parameters. 296 obese children (mean age: 11.3 years) and 138 age- and sex-matched healthy controls were included. Cases are classified as Metabolically Unhealthy Obese (MUO): One or more of the following criteria: glucose ≥ 100 mg/dL, triglycerides ≥ 150 mg/dL, HDL ≤ 40 mg/dL, or systolic/diastolic blood pressure ≥ 95th percentile, and MHO: absence of all these criteria.Vitamin B12 was categorized as deficient (< 148 pmol/L (200 pg/mL)), borderline (148-221 pmol/L(200-300 pg/mL)), or sufficient (> 221 pmol/L(> 300 pg/mL)). Using multivariate regression, vitamin B12 levels and metabolic indicators were examined. Of obese children,54.3% were in MUO.MHO and MUO groups had similar vitamin B12 levels(p = 0.051) but considerably lower than the healthy controls. Vitamin B12 insufficiency was detected in 34.3% of obese children compared with 16.1% of controls (p = 0.015). MHO group had a mean B12 level of 281.6 pg/mL, considerably lower than the controls(388.5 pg/mL; p = 0.001).Higher BMI SDS raised B12 insufficiency risk by 4.3-fold (OR = 4.307). Multivariate logistic regression analysis identified statistically significant associations between vitamin B12 deficiency and free T4 (p < 0.001, OR:0.001), AST (p = 0.011,OR:0.897), triglycerides (p = 0.032,OR:1.054), HDL (p = 0.029, OR:0.847), TG/HDL(p = 0.017,OR:0.092), and uric acid (p = 0.047,OR:1.491). Vitamin B12 deficiency is more common in obese children than in healthy controls, regardless of metabolic phenotype. Being metabolically healthy does not appear to offer protection against low vitamin B12 levels. Increased adiposity and associated metabolic alterations may also contribute to vitamin B12 deficiency. These findings underscore the importance of routinely monitoring micronutrient deficiencies in childhood obesity.

17 July 2025 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
MBMeliha Esra Bilici
Meliha Esra Bilici
ZŞZeynep Şıklar
Zeynep Şıklar
EÖElif Özsu
Elif Özsu
SCSerdar Ceylaner
Serdar Ceylaner
ZAZehra Aycan
Zehra Aycan
MBMerih Berberoğlu
Merih Berberoğlu
Objectives: Osteopetrorickets is a rare autosomal recessive disease that affects many systems and is characterized by dense bone mass and paradoxical rickets due to insufficient resorption of calcified cartilage. Its rarity and presentation with nonspecific symptoms may cause delays in diagnosis. Early diagnosis and improvement of rickets accompanying bone marrow transplantation as a curative treatment option before the development of any irreversible complications are essential for prognosis. However, the etiopathogenesis and management of rickets treatment strategies are still controversial. Case presentation: A 4-month-old female patient, whose loss of vision had been followed for 1.5 months, was admitted to our clinic with the request for a disability report. Clinical and laboratory findings were consistent with osteopetrorickets. Molecular analysis revealed a homozygous variant in the TCIRG1 gene. She was normocalcemic and hypophosphatemic, and the 25-OH vitamin D level was normal, while 1.25-dihydroxyvitamin D levels were quite high. Treatment was started with low-dose calcium replacement and calcitriol. The dose of calcitriol was gradually increased to 300 ng/kg/d, and a significant clinical response was achieved. Bone marrow transplantation was conducted at 8 months postnatally from an HLA-compatible non-related donor; nonetheless, the patient succumbed to respiratory problems on the 71st day following the procedure. Conclusions: Nonspecific symptoms of osteopetrorickets should be considered for early diagnosis, as a timely intervention in the first months of life can be life-saving. The pathophysiology of rickets remains unclear, but low calcium-phosphorus product and resistance to 1.25-dihydroxyvitamin D appear to play key roles. High-dose calcitriol and cautious calcium supplementation may improve outcomes, though further research is needed to optimize treatment strategies.

29 April 2024 in Turkish Journal of Diabetes and Obesity
Verified
Journal Article
Open access
PDF file
SBSerdar Bilici
Serdar Bilici
TETuba Gültekin Erol
Tuba Gültekin Erol
MBMeliha Esra Bilici
Meliha Esra Bilici
SUSılay Cantürk Uğurbaş
Sılay Cantürk Uğurbaş
SUSuat Hayri Uğurbaş
Suat Hayri Uğurbaş
Aim: To evaluate the effect of childhood obesity on choroidal structures with spectral-domain optical coherence tomography (SD-OCT). Material and Methods: A total of 80 children (20 children per each group; healthy, overweight, obese, and morbid-obese) were included in the study. Accompanying comorbidities such as insulin resistance, dyslipidemia, and metabolic syndrome were recorded. The subfoveal choroidal thickness (SFCT) and choroidal vascularity index (CVI) measurements were obtained from SD-OCT images and compared between groups. Results: No notable differences were found between groups regarding the means of age and axial length (p=0.504, and p=0.805, respectively). The SFCT medians (min-max) of healthy, overweight, obese, and morbid-obese children were 398.5 (319.0-453.5) μm, 299.0 (274.7-387.0) μm, 295.5 (257.0-385.0) μm, and 304.5 (272.2-386.0) μm respectively. Overweight and obese children had thinner choroid than non-obese healthy children (p=0.032). Besides, no significant correlation was observed between the severity of obesity and SFCT (p=0.722). In terms of CVI, total choroidal area, luminal area, and stromal area; no significant differences were found between groups (p=0.710, p=0.452, p=0.221, and p=0.863, respectively). Obese children with dyslipidemia had thinner SFCT than those not have dyslipidemia (292.0 (166-431)μm vs 348.0(173-491)μm, p=0.003), while insulin resistance and metabolic syndrome had no effect on SFCT (p=0.336, and p=0.211, respectively). Conclusion: Childhood obesity and accompanying dyslipidemia led to a decrease in SFCT without any significant change in the CVI. However, the severity of obesity and having insulin resistance or metabolic syndrome had no effect on either SFCT or CVI. The thinning in the SFCT may be related to microvascular disorders due to childhood obesity and dyslipidemia

10 January 2025 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
MBMeliha Esra Bilici
Meliha Esra Bilici
ZSZeynep Siklar
Zeynep Siklar
SÇSemra Çağlar Çetinkaya
Semra Çağlar Çetinkaya
EÖElif Özsu
Elif Özsu
ZAZehra Aycan
Zehra Aycan
MBMerih Berberoğlu
Merih Berberoğlu
Objectives: Premature ovarian insufficiency (POI) affects 1 in 10,000 children, with its molecular causes largely unknown. Adult studies suggest that low androgen levels induce ovarian insufficiency, but data on about this in children is limited. This study aims to assess the prevalence of low androgen levels in childhood POI and its relationship with adrenal insufficiency. Methods: Idiopathic POI adolescents were categorized into two groups based on DHEAS and total testosterone (TT) measured by chemiluminescence. Low androgen group (LAG) was defined using cut-offs according to Tanner pubarche staging. Demographic, clinical, and laboratory data were compared. Morning cortisol 96 or <5 pg/mL were planned to undergo ACTH stimulation testing, with a peak cortisol response <18 μg/dL considered insufficient. Results: Forty-three adolescents, mean age 15.5 ± 1.3 years with a 46, XX karyotype, normal FMR1 mutation, FSH levels >40 mIU/mL, and low AMH levels were included. In 14 cases (37.8 %), DHEAS and TT were low. In the LAG, pubarche was absent in seven patients, and initial height SDS was significantly lower. Morning cortisol ranged from 7.9 to 23.5 μg/dL, with an ACTH of 29.4 ± 9.7 pg/mL. No differences in adrenal steroids or correlations between DHEAS and ACTH were observed. Conclusions: Diminished androgen levels are prevalent in children with idiopathic POI. The potential for this condition to increase the risk of adrenal insufficiency and its impact on secondary ovarian insufficiency remains unclear. This study, the first of its kind in children, underscores the potential role of genetic factors in zona reticularis and ovarian development.